Gland Pharma Limited — Important, 25-12-2024: Updates

Cenexi's Fontenay Manufacturing Facility underwent a Good Manufacturing Practices (GMP) inspection by the Agence nationale de sécurité du médicament et des produits de santé (ANSM) from December 9 to 19. The inspection concluded with the facility receiving an official notification citing 10 observations. Cenexi is dedicated to addressing these observations in collaboration with ANSM and will provide updates to stakeholders as progress is made. This situation may pose certain operational challenges, but the management's commitment to corrective action suggests a proactive approach to maintaining compliance and standards, indicating a need for investors to keep a close watch on further developments.